These pieces of evidence indicate that targeting Piezo1 not only aids in understanding disease mechanisms but also provides novel therapeutic approaches for neuroprotection, analgesia, and stroke intervention (Xiao, 2024). The gene discussed is PIEZO1; the disease is stroke disorder.